Neuropeptide Y (NPY) and the endogenous melanocortin receptor antagonist, agouti gene-related protein (AGRP), coexist in the arcuate nucleus, and both exert orexigenic effects. The present study aimed primarily at determining the brain distribution of AGRP. AGRP mRNAexpressing cells were limited to the arcuate nucleus, representing a major subpopulation (95%) of the NPY neurons, which also was confirmed with immunohistochemistry. AGRP-immunoreactive (-ir) terminals all contained NPY and were observed in many brain regions extending from the rostral telencephalon to the pons, including the parabrachial nucleus. NPY-positive, AGRP-negative terminals were observed in many areas. AGRP-ir terminals were reduced dramatically in all brain regions of mice treated neonatally with monosodium glutamate as well as of mice homozygous for the anorexia mutation. Terminals immunoreactive for the melanocortin peptide ␣-melanocyte-stimulating hormone formed a population separate from, but parallel to, the AGRP-ir terminals. Our results show that arcuate NPY neurons, identified by the presence of AGRP, project more extensively in the brain than previously known and indicate that the feeding regulatory actions of NPY may extend beyond the hypothalamus.Neuropeptide Y (NPY) (1)-producing neurons in the hypothalamic arcuate nucleus (2, 3) appear to be involved in the regulation of feeding behavior. Intracerebral injections of NPY induce food intake (4, 5), and starved animals increase NPY expression (6, 7). In genetic models of feeding disorders, arcuate NPY overexpression has been linked to hyperphagia and obesity (8), and NPY deficiency has been linked to hypophagia and anorexia (9). However, surprisingly little information is available on the arcuate NPY projections, and targets for these neurons so far have been demonstrated only in a limited number of hypothalamic nuclei (10-12). Recently, Hahn et al. (13) and we (14) have reported that many NPY neurons in the rodent arcuate coexpress agouti gene-related protein (AGRP) (15), an endogenous antagonist of the anorexigenic melanocortin peptides, e.g., ␣-melanocytestimulating hormone (␣MSH) (16,17). The present study aimed at investigating whether AGRP expression is limited to arcuate NPY neurons, using double-labeling immunohistochemistry and in situ hybridization. If so, AGRP staining could be used to map the terminal projections of arcuate NPY neurons. To further ascertain the arcuate origin of AGRPimmunoreactive (ir) terminals, we also analyzed mice treated neonatally with monosodium glutamate (MSG), which induces necrosis of arcuate neurons (18), including the NPY cells (11,19). In addition, we studied AGRP in the mutant anorexia (anx͞anx) mouse, where abnormalities in arcuate NPY histochemistry have been demonstrated (9).
MATERIALS AND METHODSAnimals. C57Bl6 mice (B&K Universal, Sollentuna, Sweden) were injected s.c. with MSG (Sigma) at doses of 2.2, 2.5, 2.8, 3.2, 3.4, 3.6, 3.8, 4.0, and 4.2 mg͞g or 0.9% NaCl (vehicle) on postnatal days 2-10, respectively (20). Four MSG...